Haftamu Ebuy1, Henock Yebyo2, Mussie Alemayehu2. 1. Dr. Tewelde Legesse College of Health Sciences, PO Box 106, Mekelle, Ethiopia. Electronic address: hafebuy@yahoo.com. 2. Department of Public Health, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.
Abstract
OBJECTIVE: The aim of this study was to determine the level of adherence to Option B+ PMTCT drugs and factors associated with adherence among HIV-positive pregnant women in public hospitals of Tigray, northern Ethiopia. METHODS: A cross-sectional study was conducted among 277 HIV-positive pregnant women in 2014. A two-stage cluster sampling technique was used to select the study participants. Individual consent was obtained from each participant. Multivariate logistic regression was used to estimate the net effect sizes of factors associated with adherence to Option B+ PMTCT drugs. RESULTS: The level of adherence of respondents to Option B+ PMTCT drugs was 87.1% (95% confidence interval (CI) 82.6-90.7%). Controlling for the effect of other factors, the odds of adhering to Option B+ PMTCT were 4.7 times higher among women who received counselling on medication as compared to those who did not (adjusted odds ratio (aOR) 4.7, 95% CI 1.98-11.35). Similarly, disclosing HIV status was positively associated with good adherence (aOR 4.2, 95% CI 1.07-16.33). CONCLUSIONS: The adherence level was found to be reasonably good. Counselling on medication and HIV status disclosure were positive predictors of adherence to Option B+ PMTCT drugs.
OBJECTIVE: The aim of this study was to determine the level of adherence to Option B+ PMTCT drugs and factors associated with adherence among HIV-positive pregnant women in public hospitals of Tigray, northern Ethiopia. METHODS: A cross-sectional study was conducted among 277 HIV-positive pregnant women in 2014. A two-stage cluster sampling technique was used to select the study participants. Individual consent was obtained from each participant. Multivariate logistic regression was used to estimate the net effect sizes of factors associated with adherence to Option B+ PMTCT drugs. RESULTS: The level of adherence of respondents to Option B+ PMTCT drugs was 87.1% (95% confidence interval (CI) 82.6-90.7%). Controlling for the effect of other factors, the odds of adhering to Option B+ PMTCT were 4.7 times higher among women who received counselling on medication as compared to those who did not (adjusted odds ratio (aOR) 4.7, 95% CI 1.98-11.35). Similarly, disclosing HIV status was positively associated with good adherence (aOR 4.2, 95% CI 1.07-16.33). CONCLUSIONS: The adherence level was found to be reasonably good. Counselling on medication and HIV status disclosure were positive predictors of adherence to Option B+ PMTCT drugs.
Authors: Christine J McGrath; Benson Singa; Agnes Langat; John Kinuthia; Keshet Ronen; Danvers Omolo; Benjamin Elly Odongo; Rose Wafula; Prisca Muange; Abraham Katana; Lucy Ng'anga'; Grace C John-Stewart Journal: AIDS Care Date: 2017-11-11
Authors: Monisha Sharma; Jennifer A Smith; Carey Farquhar; Roger Ying; Peter Cherutich; Matthew Golden; Beatrice Wamuti; David Bukusi; Hans Spiegel; Ruanne V Barnabas Journal: AIDS Date: 2018-01-14 Impact factor: 4.177
Authors: Tamsin Phillips; Annibale Cois; Robert H Remien; Claude A Mellins; James A McIntyre; Greg Petro; Elaine J Abrams; Landon Myer Journal: PLoS One Date: 2016-10-19 Impact factor: 3.240